Approval · Notice of Compliance 26802 · 2021
TECFIDERA: Notice of Compliance 26802
Issued October 8, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26802
- Date
- October 8, 2021
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph and to migrate the product monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECFIDERA | Not yet assigned | — |
Medicinal ingredients
- DIMETHYL FUMARATE 120 MG per CAP
- DIMETHYL FUMARATE 240 MG per CAP